Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related PFE
Pfizer Should Outperform, Morgan Stanley Upgrades
Benzinga's Top Upgrades, Downgrades For September 20, 2017
US Market Indexes Gain on Wednesday (GuruFocus)
Related LNKD
How Public Relations Firms Are Capitalizing On The Marijuana Green Rush
Non-Horrible Bosses: Meet The Best CEOs Of 2017

Analysts at Citigroup initiated coverage on shares of Pfizer (NYSE: PFE) with a “buy” rating. Pfizer's shares closed at $24.85 yesterday. Pfizer's trailing-twelve-month operating margin is 31.27%.

Wedbush initiated coverage on shares of LinkedIn (NYSE: LNKD) with a “neutral” rating. LinkedIn's stock closed at $107.11 yesterday. LinkedIn's trailing-twelve-month ROE is 2.76%.

Wells Fargo initiated coverage on shares of Hess (NYSE: HES) with a “market perform” rating. Hess' shares closed at $50.50 yesterday. Hess had $528.00 million in total cash for the recent quarter.

Analysts at Mizuho initiated coverage on shares of Salix Pharmaceuticals (NASDAQ: SLXP) with a “buy” rating. Salix's shares closed at $41.26 yesterday. Salix's PEG ratio is 0.62.

Latest Ratings for PFE

DateFirmActionFromTo
Sep 2017Morgan StanleyUpgradesEqual-WeightOverweight
Aug 2017BMO CapitalUpgradesMarket PerformOutperform
Jul 2017Credit SuisseMaintainsNeutral

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (HES + LNKD)

View Comments and Join the Discussion!
Loading...
Loading...